GRAAPH2014, NCT02611492: A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults |
|
|
| Recruiting | 3 | 265 | Europe | Nilotinib, Methotrexate, Aracytine (Ara C), Granulocyte Colony-Stimulating Factor (G-CSF), Depomedrol, Dexamethasone, Vincristine, Imatinib, 6 Mercaptopurine (6MP) | Assistance Publique - Hôpitaux de Paris | Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia | 12/20 | 12/25 | | |
